BackgroundNeonatal hypoxic–ischemic encephalopathy (HIE) stands as a primary cause of neonatal brain injury, mortality, and long-term neurodevelopmental impairment, imposing a considerable burden on public health systems worldwide. Despite advances in clinical practice, accurate early diagnosis and reliable severity stratification of HIE remain formidable challenges when relying solely on convent…
